IL-21 Promotes Pulmonary Fibrosis through the Induction of Profibrotic CD8+ T Cells

被引:46
作者
Brodeur, Tia Y. [1 ]
Robidoux, Tara E. [1 ]
Weinstein, Jason S. [2 ]
Craft, Joseph [2 ]
Swain, Susan L. [3 ]
Marshak-Rothstein, Ann [1 ]
机构
[1] Univ Massachusetts, Sch Med, Dept Med, Div Rheumatol, Worcester, MA 01605 USA
[2] Yale Univ, Sch Med, Dept Internal Med, Rheumatol Sect, New Haven, CT 06520 USA
[3] Univ Massachusetts, Sch Med, Dept Pathol, Worcester, MA 01605 USA
基金
美国国家卫生研究院;
关键词
SYSTEMIC-SCLEROSIS; AIRWAY HYPERRESPONSIVENESS; FIBROTIC DISEASE; TISSUE FIBROSIS; SKIN FIBROSIS; LUNG INJURY; TGF-BETA; RECEPTOR; BLEOMYCIN; INFLAMMATION;
D O I
10.4049/jimmunol.1500777
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Type 2 effector production of IL-13, a demonstrated requirement in models of fibrosis, is routinely ascribed to CD4(+) Th2 cells. We now demonstrate a major role for CD8(+) T cells in a murine model of sterile lung injury. These pulmonary CD8(+) T cells differentiate into IL-13-producing Tc2 cells and play a major role in a bleomycin-induced model of fibrosis. Differentiation of these Tc2 cells in the lung requires IL-21, and bleomycin treated IL-21- and IL-21R-deficient mice develop inflammation but not fibrosis. Moreover, IL-21R-expressing CD8(+) cells are sufficient to reconstitute the fibrotic response in IL-21R-deficient mice. We further show that the combination of IL-4 and IL-21 skews naive CD8(+) T cells to produce IL-21, which, in turn, acts in an autocrine manner to support robust IL-13 production. Our data reveal a novel pathway involved in the onset and regulation of pulmonary fibrosis and identify Tc2 cells as key mediators of fibrogenesis.
引用
收藏
页码:5251 / 5260
页数:10
相关论文
共 55 条
  • [1] Atamas SP, 1999, ARTHRITIS RHEUM, V42, P1168, DOI 10.1002/1529-0131(199906)42:6<1168::AID-ANR13>3.0.CO
  • [2] 2-L
  • [3] IL-21 inhibits T cell IL-2 production and impairs Treg homeostasis
    Attridge, Kesley
    Wang, Chun Jing
    Wardzinski, Lukasz
    Kenefeck, Rupert
    Chamberlain, Jayne L.
    Manzotti, Claire
    Kopf, Manfred
    Walker, Lucy S. K.
    [J]. BLOOD, 2012, 119 (20) : 4656 - 4664
  • [4] Interaction of IL-13 and C10 in the pathogenesis of bleomycin-induced pulmonary fibrosis
    Belperio, JA
    Dy, M
    Burdick, MD
    Xue, YY
    Li, KW
    Elias, JA
    Keane, MP
    [J]. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 2002, 27 (04) : 419 - 427
  • [5] Migration kinetics and final destination of type 1 and type 2 CD8 effector cells predict protection against pulmonary virus infection
    Cerwenka, A
    Morgan, TM
    Harmsen, AG
    Dutton, RW
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 189 (02) : 423 - 434
  • [6] IL-23 Drives Pathogenic IL-17-Producing CD8+ T Cells
    Ciric, Bogoljub
    El-behi, Mohamed
    Cabrera, Rosalyn
    Zhang, Guang-Xian
    Rostami, Abdolmohamad
    [J]. JOURNAL OF IMMUNOLOGY, 2009, 182 (09) : 5296 - 5305
  • [7] GENERATION OF POLARIZED ANTIGEN-SPECIFIC CD8 EFFECTOR POPULATIONS - RECIPROCAL ACTION OF INTERLEUKIN (IL)-4 AND IL-12 IN PROMOTING TYPE-2 VERSUS TYPE-1 CYTOKINE PROFILES
    CROFT, M
    CARTER, L
    SWAIN, SL
    DUTTON, RW
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 180 (05) : 1715 - 1728
  • [8] IL-13-producing BLT1-positive CD8 cells are increased in asthma and are associated with airway obstruction
    Dakhama, A.
    Collins, M. L.
    Ohnishi, H.
    Goleva, E.
    Leung, D. Y. M.
    Alam, R.
    Sutherland, E. R.
    Martin, R. J.
    Gelfand, E. W.
    [J]. ALLERGY, 2013, 68 (05) : 666 - 673
  • [9] Natural killer T cells and CD8+ T cells are dispensable for T cell-dependent allergic airway inflammation
    Das, Jyoti
    Eynott, Paul
    Jupp, Ray
    Bothwell, Alfred
    Van Kaer, Luc
    Shi, Yufang
    Das, Gobardhan
    [J]. NATURE MEDICINE, 2006, 12 (12) : 1345 - 1346
  • [10] Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair
    Duffield, JS
    Forbes, SJ
    Constandinou, CM
    Clay, S
    Partolina, M
    Vuthoori, S
    Wu, SJ
    Lang, R
    Iredale, JP
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2005, 115 (01) : 56 - 65